Kateryna Rudnieva
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (12)
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Introduction <i>Staphylococcus aureus</i> plays a significant role in the development of the clinical picture in patients with atopic dermatitis. The use of commensal microflora can be a promising direction in treatment of atopic dermatitis. Aim The aim of this study is the selection of the optimal safe isolate of <i>S. hominis</i> for bacteriotherapy in patients with atopic dermatitis. Material and methods Sensitivity of isolates of<i> S. hominis</i> ssp.<i> hominis</i> to antibacterial drugs was determined by the disk-diffusion method on Mueller–Hinton agar (HiMedia, India). The ability to form a biofilm was determined by measuring the amount of dye absorption by the biofilm on a microplate reader MR-96A (Mindray, China) at a wavelength of 495 nm. Antagonism in vitro was determined by the method of perpendicular strokes on the blood agar. In total, 24 adult volunteers (aged 18 to 60 years) were screened and included in the study. The results were calculated according to the zone of <i>S. aureus</i> growth retardation under the influence of metabolic products of<i> S. hominis</i> ssp. <i>hominis</i>. Results and Discussion As a result of the study of 8 isolates of <i>S. hominis</i> ssp. <i>hominis</i>, which were obtained from the swabs taken from healthy skin of 24 people, one isolate of <i>S. hominis</i> ssp. <i>hominis</i> Hom-2 met all criteria of safety – Hom-2 demonstrated sensitivity to the studied antibiotics and formed a biofilm of low density (OD 0.15), and effectiveness (morphological and cultural properties, antagonistic effect on <i>S. aureus</i>). Conclusions In this work, an isolate of <i>S. hominis</i> ssp. <i>hominis</i> Hom-2 met all criteria of safety and efficacy and will be used in the further study of bacteriotherapy in patients with atopic dermatitis.
Year:
2023
A significant number of microorganisms in natural and artificial environments exist in a structured formation – biofilm. This formation attaches to a certain surface, particularly the epithelium. The ability to form a similar structure has been observed in Pasteurella multocida, the causative agent of anthropozoonoses that affect domestic and wild animals, birds, companion animals and humans. The spectrum of pathogenetic action of P. multocida is wide and associated with the development of respiratory and multisystemic pathology, bacteraemia and other manifestations. Timely detection of P. multocida and treatment of the diseases it causes in farm and domestic animals is important to limit economic losses and improve social security. The main objective of this study was to determine the pathogenicity of P. multocida, its ability to form a biofilm, its resistance to antibiotics, and to identify the genes responsible for the formation of dermonecrotic toxin and biofilm formation. The paper presents the results of a study of 11 isolates of P. multocida: six isolates (54.5%) from rabbits, two isolates (18.2%) from dogs, two isolates (18.2%) from cats, and one isolate from pigs (9.2%). In all isolates, the gene ptfA was detected. This gene encodes the formation of type 4 fimbriae and participates in the formation of the biofilm, and the studied cultures in vitro formed a biofilm of different densities. The genome of eight isolates (72.7%) included the toxA gene (provides the formation of dermonecrotic toxin), while 45.4% of isolates had a complete set of the studied signs of pathogenicity, both in phenotypic (biofilm formation, mortality for laboratory animals) and genotypic (presence of toxA, ptfA) traits, and three isolates (27.3%) showed signs of multidrug resistance. The virulence of the toxA-negative isolates of P. multocida was lower than in toxA-positive isolates. The culture with the highest virulence (0.5x 101 CFU) and extreme resistance to antibiotics formed a biofilm of the highest density. The association of the gene in the biofilm-producing mechanism needs further evaluation, and further research is needed to identify the relationships between pathogens in Pasteurella multocida isolates from different species of animals and humans.
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Collaborators (6)
Tetiana Tykhomyrova
-
Stephen Woolley
Senior Clinical Lecturer in Medical Parasitology & Microbiology (Department of Clinical Sciences) & Clinical Director- Clinical Diagnostic Parasitology Laboratory
Liverpool School of Tropical Medicine
Matthew O'Shea
Professor of Clinical Infectious Diseases and Microbiology
University of Birmingham
Luke Moore
Honorary Clinical Senior Lecturer
Imperial College London
Andrew Spiers
Reader in Environmental and Molecular Microbiology
Abertay University
Valerii Ushkalov
-
Make your next move.
Prepare your application
Review drafts before you send them.